İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

ÖZDEN ALTUNDAĞ

PROFESÖR

BAŞKENT ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Makale 167 YÖKSİS · 167 OpenAlex · 0
Proje 0
Kitap 0
Bildiri 10

Yayın sayısı iki kaynaktan gelir ve her kaynak ayrı gösterilir: YÖKSİS (akademisyen beyanı) ve OpenAlex (açık akademik katalog). Patent ve sanatsal etkinlikler aşağıdaki Çalışmalar sekmelerinde yer alır.

Araştırma konuları

OpenAlex

Dizin çeyrekleri

Scopus (SJR)

163 Toplam

  • Q1 91
  • Q2 46
  • Q3 24
  • Q4 2
Diğer sayımlar
  • YÖKSİS satırı 163 Q1 0 Q2 0 Q3 0 Q4 0

WoS (JCR)

165 Toplam

  • Q1 58
  • Q2 28
  • Q3 28
  • Q4 51
Diğer sayımlar
  • YÖKSİS satırı 165 Q1 0 Q2 0 Q3 0 Q4 0

TR Index

4 makale

OpenAlex atıf yüzdelikleri

Üst %1 makale 1
Üst %10 makale 2
Ort. yüzdelik 61.3%
Yüzdelikli makale 9

OpenAlex atıf yüzdeliği; kapsanan yayınlar (~%52).

Bu göstergeler ne anlama geliyor?
  • Q1–Q4: Yayının çıktığı derginin ilgili indeksteki (Scopus/WoS) çeyrek dilimi. Q1 en üst %25, Q4 en alt %25.
  • Üst %1 / üst %10: Aynı alan ve yılda, dünyada en çok atıf alan %1 veya %10 içindeki yayın sayısı.
  • Ort. yüzdelik: Yayınların atıf persentillerinin ortalaması (100 = en üst).
  • Kaynak: indeks çeyrekleri Scopus/WoS ve TR Index bayrakları; atıf persentilleri OpenAlex.

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

64 dergi

Makale listesi

  1. 2026 Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy IN VIVO DOI 10.21873/invivo.14216 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 96.6%
  2. 2026 Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA PET-CT Reports MOLECULAR IMAGING AND BIOLOGY DOI 10.1007/s11307-025-02072-7 YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.9%
  3. 2025 Large Language Models for Analyzing Cancer Drug Reimbursement Policies in Türkiye's Health Practice Regulation TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY DOI 10.5505/tjo.2025.4563 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 30.9%
  4. 2025 Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival Perspective CURRENT ONCOLOGY DOI 10.3390/curroncol33010017 YÖKSİS JCR Q2
  5. 2025 Simulating a virtual tumor board with large language models: a pilot study in NSCLC patients receiving immunotherapy IMMUNOTHERAPY DOI 10.1080/1750743X.2025.2580272 YÖKSİS SJR Q3 JCR Q3 OpenAlex 89.8%
  6. 2025 Posttransplant Malignancies in Adult Transplant Patients EXPERIMENTAL AND CLINICAL TRANSPLANTATION DOI 10.6002/ect.2025.0081 YÖKSİS SJR Q3 JCR Q4
  7. 2025 Artificial intelligence for immunotherapy response assessment in lung cancer using PET/CT reports JAPANESE JOURNAL OF RADIOLOGY DOI 10.1007/s11604-025-01840-3 YÖKSİS SJR Q1 JCR Q1
  8. 2025 Recurrence of Hepatocellular Carcinoma After Liver Transplant: A Single-Center Experience EXPERIMENTAL AND CLINICAL TRANSPLANTATION DOI 10.6002/ect.2025.0041 YÖKSİS SJR Q3 JCR Q4
  9. 2024 Incidence and Clinical Characteristics of Drug-Induced Lung Disease Among Chemotherapy Recipients Cureus DOI 10.7759/cureus.63408 YÖKSİS JCR Q2 OpenAlex 14.9%
  10. 2022 Recent Advances in Systemic Therapy for Hepatocellular Carcinoma Experimental and Clinical Transplantation DOI 10.6002/ect.2021.0478 YÖKSİS SJR Q3 JCR Q4
  11. 2022 Solid-Organ Transplantation From Deceased and Living Donors With Cancer or a History of Cancer Experimental and Clinical Transplantation DOI 10.6002/ect.DonorSymp.2022.L30 YÖKSİS SJR Q3 JCR Q4
  12. 2022 Survival in recurrent ovarian cancer patients before and after the bevacizumab era: an observational single-centre study Journal of Obstetrics and Gynaecology DOI 10.1080/01443615.2022.2036967 YÖKSİS SJR Q3 JCR Q4 OpenAlex 65.4%
  13. 2022 Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer New England Journal of Medicine DOI 10.1056/NEJMoa2108330 YÖKSİS SJR Q1 JCR Q1
  14. 2021 Survival impact of number of removed para-aortic lymph nodes in stage I epithelial ovarian cancer Archives of Gynecology and Obstetrics DOI 10.1007/s00404-021-06190-9 YÖKSİS SJR Q2 JCR Q3
  15. 2021 Complications of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: An evaluation of 100 cases International Journal of Gynecology & Obstetrics DOI 10.1002/ijgo.13767 YÖKSİS SJR Q1 JCR Q1
  16. 2021 Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer New England Journal of Medicine DOI 10.1056/NEJMoa2112435 YÖKSİS SJR Q1 JCR Q1
  17. 2020 Vismodegib Experience in a Renal Transplant Patient With Basal Cell Carcinoma Experimental and Clinical Transplantation DOI 10.6002/ect.2019.0293 YÖKSİS SJR Q3 JCR Q4
  18. 2020 Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging Journal of Obstetrics and Gynaecology DOI 10.1080/01443615.2020.1737661 YÖKSİS SJR Q3 JCR Q4
  19. 2020 Single-Center Experience of Recurrence Patterns and Survival Analyses of Patients With Hepatocellular Carcinoma and Liver Transplant Experimental and Clinical Transplantation DOI 10.6002/ect.2020.0046 YÖKSİS SJR Q3 JCR Q4
  20. 2019 Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging International Journal of Radiation Oncology*Biology*Physics DOI 10.1016/j.ijrobp.2019.06.1671 YÖKSİS SJR Q1 JCR Q1

Akademisyenlere dön